Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Centre De Bouskoura , Bp N°1
Casablanca; Casablanca - Settat; Map
Tel: +212-052232
Fax: +212-052233
Email: @sothema.ma / a.chebihi@sothema.ma
Website: http://www.sothema.com

Full name: Societe De Therapeutique Marocaine Sa

Status: Listed
Legal Form: Joint Stock Company
Operational Status: Operational
EMISid: 2272384
ISIN: MA0000011645
Incorporation Date: 1976

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Pharmaceutical products

Company Description

Sothema SA is a Morocco-based company specialized in the production and marketing of drugs, created on 26/01/1976 and the IPO dated on 21/02/2005. The Company provides drugs in the forms of tablets, capsules, syrups, ampoules, creams and ointments, as well as powders and suspensions for injections, among others. It exports the substantial share of its output to Europe, North and sub-Saharan Africa, among others, and it is also engaged in the manufacture of drugs under license and the importation of dental…

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 1,250.00
Volume 0
Turnover n/a
Index    MASI Float (MASI)
Market Casablanca Stock Exchange
Ticker SOT
Market Cap Market Cap 2,250,000
52 Week High 1,377.00
52 Week Low 1,175.00
Price to Earnings (P/E) 15.14
Earnings per Share (EPS) 82.55
Dividend Yield 48 (July 04, 2016)
Bookvalue 1,038,889
Enterprise Value 2,424,838
Quote updated on April 26, 2017
Note: data in MAD Thousands.

Key Executives

Executive Vice President
More

Ownership Details

Omar Tazi
31.82%
More

Key Stats

Select Items to chart them. 2016 Q2C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 1,146,378
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Morocco

MAD | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest